Friday, July 11, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Exports

Exports: India ships pharma products to 200 countries, says Chawla

Fiinews by Fiinews
November 21, 2023
in Exports
Reading Time: 3 mins read
A A
0
Panacea Biotech
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Govt policies are conducive for growth of pharma sector

India has largest number of FDA approved plants, and exports pharma products to 200 countries with worth more than US$50 billion, according to Arunish Chawla, Secretary, Department of Pharmaceuticals.

As such, India has the potential to grow 3-4 times in value by achieving a shift from 10% share of Pharma and MedTech in manufacturing sector in 2020 to 20% share in 2030, he told delegates at CII 5th Life Sciences Summit 2023 held on 17 Nov in New Delhi.

“Currently Life Sciences industry is at its EDGE, where E is for efficiency, D for Demographic Dividend, G is for Government policy and E for Economies of scale, he elaborated.

He emphasized on 3 key themes – Policy, Research, and Industrial Strategy.

“Innovation is on rise in India – MedTech, assistive technology and smart medicine is evolving but a streamlined innovation strategy is required.”

Silos need to be broken between academia, laboratories, and industry. A shift is required from publications to patents and a mechanism for research oriented sponsored degrees from industry is the need of the hour to foster innovation, said Chawla.

India has undergone a structural change and has become an active exporter from passive importer, he pointed out.

He called on the Indian pharma industry to utilize its technical resources, demographic dividend, skilled manpower, forward looking government policies and economies of scale to become a world leader in Pharmaceuticals.

Policies introduced by the government are conducive to the growth of the sector, added Dr Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) in his address to the CII delegates.

Emphasizing the need for innovation, he wants the industry to appreciate initiatives like 100% FDI through direct route for greenfield projects.

He also wants the industry to focus on national policy on R & D for MedTech and Pharma, increase in investments and government support through BIRAC that funds startups for proof of concept, availability of alternate funds and so on. He emphasized that Corporate Venture Funds are required from industry to handhold startups and international scale up.

“Focus on developing research and innovation framework of the country and development of Bio-Manufacturing in India,” said Kumar.

India is now a global force in Active Ingredients space and is emerging as a major player in manufacturing and supply of vaccines, according to G V Prasad, Chairman, CII National Committee on Pharmaceuticals and Co-Chairman & Managing Director, Dr Reddy’s Laboratories Limited.

He highlighted the importance of reforming business models, self-reliance, innovation, and global collaboration for enterprises in the Life Sciences domain.

Biological drugs and biosimilars is a major area which drives growth in India, added Prasad.

He pointed out that CII’s work will continue to focus on promoting vertical integration in supply chain, strengthening the domestic manufacturing to reduce import dependency, strengthening ecosystem for Innovation including industry-academia collaboration, improving market access and the economic growth of the sector, improving global supply chain issues for combating future global pandemics and to address regulatory issues at the national and state level and work for improving Ease of Doing Business in Pharma.

The sector’s current landscape is very optimistic and is showing unprecedented growth, according to Dr Rajesh Jain, Chairman, CII National Committee on Biotechnology and Chairman & Managing Director, Panacea Biotech Ltd.

He appreciated the active support of Government through various policies and reforms like Make in India and DBT.

He emphasized that Biotech incubators and startups are the growth drivers, and the number of such startups will increase to 10,000 by next year.

CII’s focus this year will be to facilitate improvements in the Regulatory Framework, make it transparent, simple, and harmonized to promote the research and development of the sector, assured Jain.

He called for upscaling cell and Gene therapy, skilling and training of regulatory workforce, improvements in IP and Biodiversity law aspects, Industry-academia collaboration and vaccine development will be other important areas of attention by CII. Fiinews.com

Tags: CII
ShareTweetShare

Related Posts

Agriculture Of Bihar
Exports

Export: Rs20lcr potential for agriculture supplies

by Fiinews
July 11, 2025
0
20

Minister calls on entrepreneurs to collaborate with farmers Commerce and Industry Minister Piyush Goyal sees Indian agricultural exports potential to...

PIB
Exports

Export: India-SACU PTA talks to be expedited

by Fiinews
July 11, 2025
0
19

PM-Prez discussed ties in Windhoek Prime Minister Narendra Modi and President of Namibia Dr. Netumbo Nandi-Ndaitwah have discussed expediting India-SACU...

PIB

Export: India-Brazil set $20bn trade target

July 10, 2025
24
SOPA

Export: India to ship non-GMO soybean to EU

July 7, 2025
21
Toy Biz International2

Export: India supplies toys to 153 countries

July 6, 2025
19
Ministry of Textile

Export: Govt to facilitate easy trade environment

July 2, 2025
18
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Project: Japanese delegation inspects DMIC progress
  • Project: Mindset change is critical for innovation
  • Project: 4,000% in installed solar capacity
  • Project: EV policies part of climate goals
  • Tech: ansrsource-ANSR reshape talent across India

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.